Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CHF | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 5,807 | 5,847 | 6,377 | 4,404 | 4,399 | 3,860 | 4,372 | 5,198 | 4,377 | 4,152 | | 4,152 |
% Growth | NA | 0.7% | 9.1% | -30.9% | -0.1% | -12.3% | 13.3% | 18.9% | -15.8% | -5.1% | | |
| | | | | | | | | | | | |
Cost of Revenue | (4,020) | (4,049) | (4,465) | (3,032) | (3,015) | (2,656) | (3,070) | (3,705) | (3,177) | (2,925) | | (2,925) |
Gross Profit | 1,787 | 1,798 | 1,912 | 1,372 | 1,384 | 1,204 | 1,302 | 1,493 | 1,200 | 1,227 | | 1,227 |
% Revenue | 30.8% | 30.8% | 30.0% | 31.2% | 31.5% | 31.2% | 29.8% | 28.7% | 27.4% | 29.6% | | 29.6% |
| | | | | | | | | | | | |
Research and Development | (221) | (221) | (234) | (191) | (185) | (184) | (164) | (167) | (164) | (133) | | (133) |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (1,067) | (1,084) | (1,157) | (856) | (1,027) | (681) | (694) | (745) | (639) | (738) | | (738) |
Other Inc / (Exp) | (124) | (74) | (20) | 30 | 1 | (59) | 9 | (500) | (89) | 89 | | 89 |
Total Operating Exp | (1,412) | (1,379) | (1,411) | (1,017) | (1,211) | (924) | (849) | (1,412) | (892) | (782) | | (782) |
| | | | | | | | | | | | |
Operating Income | 375 | 419 | 501 | 355 | 173 | 280 | 453 | 81 | 308 | 445 | | 445 |
% Revenue | 6.5% | 7.2% | 7.9% | 8.1% | 3.9% | 7.3% | 10.4% | 1.6% | 7.0% | 10.7% | | 10.7% |
| | | | | | | | | | | | |
Interest Expense | (75) | (81) | (64) | (74) | (102) | (49) | (59) | (75) | (90) | (75) | | (75) |
Pre-tax Income | 300 | 338 | 437 | 281 | 71 | 231 | 394 | 6 | 218 | 370 | | 370 |
Earnings of Discontinued Ops. | 12 | 0 | 0 | 143 | 72 | 678 | 81 | 217 | (34) | 0 | | 0 |
Provision for Taxes | (73) | (75) | (135) | (68) | (105) | (101) | (102) | (107) | (5) | (90) | | (90) |
Net Income to Company | 239 | 263 | 302 | 356 | 38 | 808 | 373 | 116 | 179 | 280 | | 280 |
% Margin | 4.1% | 4.5% | 4.7% | 8.1% | 0.9% | 20.9% | 8.5% | 2.2% | 4.1% | 6.7% | | 6.7% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (10) | (10) | (25) | (19) | (28) | (24) | (29) | (32) | (45) | (36) | | (36) |
Net Income to Stockholders | 229 | 253 | 277 | 337 | 10 | 784 | 344 | 84 | 134 | 244 | | 244 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | (12) | 0 | 0 | (143) | (72) | (678) | (81) | (217) | 34 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 217 | 253 | 277 | 194 | (62) | 106 | 263 | (133) | 168 | 244 | | 244 |
% Margin | 3.7% | 4.3% | 4.3% | 4.4% | -1.4% | 2.7% | 6.0% | -2.6% | 3.8% | 5.9% | | 5.9% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.67 | 0.78 | 0.84 | 0.59 | (0.19) | 0.32 | 0.80 | (0.40) | 0.51 | 0.74 | | 0.74 |
Diluted EPS (Continuing Ops) | 0.67 | 0.78 | 0.84 | 0.59 | (0.19) | 0.32 | 0.80 | (0.40) | 0.51 | 0.74 | | 0.74 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 322.20 | 323.71 | 328.31 | 329.61 | 329.59 | 329.52 | 329.34 | 329.16 | 328.96 | 328.72 | | 328.72 |
WA Diluted Shares Out. | 324.38 | 325.37 | 330.01 | 330.45 | 330.48 | 331.02 | 331.39 | 330.77 | 330.60 | 330.33 | | 330.33 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 300 | 338 | 437 | 281 | 71 | 231 | 394 | 6 | 218 | 370 | | 370 |
Addback: Net Interest Expense | 75 | 81 | 64 | 74 | 102 | 49 | 59 | 75 | 90 | 75 | | 75 |
Addback: Other Non Operating Expenses, Total | 27 | (12) | (125) | (91) | (41) | (15) | (54) | (50) | (68) | (60) | | (60) |
Addback: Depreciation & Amortization | 257 | 265 | 301 | 325 | 272 | 269 | 213 | 222 | 185 | 201 | | 201 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 114 | 103 | 176 | 78 | 50 | 99 | 53 | 567 | 183 | (24) | | (24) |
Adjusted EBITDA | 773 | 780 | 853 | 667 | 454 | 633 | 665 | 820 | 608 | 562 | | 562 |
% Margin | 13.3% | 13.3% | 13.4% | 15.1% | 10.3% | 16.4% | 15.2% | 15.8% | 13.9% | 13.5% | | 13.5% |
| | | | | | | | | | | | |
Adjusted EBIT | 516 | 515 | 552 | 342 | 182 | 364 | 452 | 598 | 423 | 361 | | 361 |
% Margin | 8.9% | 8.8% | 8.7% | 7.8% | 4.1% | 9.4% | 10.3% | 11.5% | 9.7% | 8.7% | | 8.7% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 239 | 263 | 302 | 356 | 38 | 808 | 373 | 116 | 179 | 280 | | 280 |
Addback: Unusual Items | 114 | 108 | 176 | 78 | 50 | 99 | 53 | 567 | 183 | (24) | | (24) |
Less: Tax Benefit of Unusual Items (26%) | (30) | (28) | (46) | (20) | (13) | (26) | (14) | (147) | (48) | 6 | | 6 |
Adjusted Net Income | 323 | 343 | 432 | 414 | 75 | 881 | 412 | 536 | 314 | 262 | | 262 |
% Margin | 5.6% | 5.9% | 6.8% | 9.4% | 1.7% | 22.8% | 9.4% | 10.3% | 7.2% | 6.3% | | 6.3% |